vs

Side-by-side financial comparison of Finwise Bancorp (FINW) and Outset Medical, Inc. (OM). Click either name above to swap in a different company.

Finwise Bancorp is the larger business by last-quarter revenue ($42.7M vs $28.9M, roughly 1.5× Outset Medical, Inc.). Finwise Bancorp runs the higher net margin — 6.4% vs -67.5%, a 73.9% gap on every dollar of revenue. Over the past eight quarters, Finwise Bancorp's revenue compounded faster (47.0% CAGR vs 1.2%).

Finwise Bancorp is a U.S.-based financial holding company that operates primarily through its community banking subsidiary. It offers a full suite of retail and commercial financial services, including deposit accounts, personal loans, mortgage products, small business financing, and wealth management solutions, serving local retail consumers and small to medium-sized business clients across its regional operating markets.

Outset Medical, Inc. is a medical technology company focused on developing and commercializing innovative dialysis solutions for patients living with kidney disease. Its flagship Tablo Hemodialysis System supports use in acute care facilities, outpatient clinics, and home settings, serving healthcare providers and patients across the U.S. and select international markets.

FINW vs OM — Head-to-Head

Bigger by revenue
FINW
FINW
1.5× larger
FINW
$42.7M
$28.9M
OM
Higher net margin
FINW
FINW
73.9% more per $
FINW
6.4%
-67.5%
OM
Faster 2-yr revenue CAGR
FINW
FINW
Annualised
FINW
47.0%
1.2%
OM

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FINW
FINW
OM
OM
Revenue
$42.7M
$28.9M
Net Profit
$2.7M
$-19.5M
Gross Margin
42.4%
Operating Margin
-61.1%
Net Margin
6.4%
-67.5%
Revenue YoY
-2.0%
Net Profit YoY
24.0%
EPS (diluted)
$0.20
$0.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FINW
FINW
OM
OM
Q1 26
$42.7M
Q4 25
$46.9M
$28.9M
Q3 25
$36.7M
$29.4M
Q2 25
$25.1M
$31.4M
Q1 25
$22.1M
$29.8M
Q4 24
$21.1M
$29.5M
Q3 24
$20.8M
$28.7M
Q2 24
$19.8M
$27.4M
Net Profit
FINW
FINW
OM
OM
Q1 26
$2.7M
Q4 25
$3.9M
$-19.5M
Q3 25
$4.9M
$-17.8M
Q2 25
$4.1M
$-18.5M
Q1 25
$3.2M
$-25.8M
Q4 24
$2.8M
$-25.6M
Q3 24
$3.5M
$-27.9M
Q2 24
$3.2M
$-34.5M
Gross Margin
FINW
FINW
OM
OM
Q1 26
Q4 25
42.4%
Q3 25
39.4%
Q2 25
37.8%
Q1 25
37.2%
Q4 24
36.5%
Q3 24
34.3%
Q2 24
35.7%
Operating Margin
FINW
FINW
OM
OM
Q1 26
Q4 25
11.7%
-61.1%
Q3 25
17.5%
-53.7%
Q2 25
21.7%
-53.7%
Q1 25
20.1%
-55.1%
Q4 24
17.5%
-74.2%
Q3 24
22.2%
-83.2%
Q2 24
21.1%
-112.3%
Net Margin
FINW
FINW
OM
OM
Q1 26
6.4%
Q4 25
8.4%
-67.5%
Q3 25
13.3%
-60.6%
Q2 25
16.3%
-59.0%
Q1 25
14.4%
-86.7%
Q4 24
13.2%
-87.0%
Q3 24
16.6%
-97.5%
Q2 24
16.1%
-125.8%
EPS (diluted)
FINW
FINW
OM
OM
Q1 26
$0.20
Q4 25
$0.27
$0.33
Q3 25
$0.34
$-1.00
Q2 25
$0.29
$-1.04
Q1 25
$0.23
$-3.66
Q4 24
$0.19
$-7.21
Q3 24
$0.25
$-8.02
Q2 24
$0.24
$-9.96

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FINW
FINW
OM
OM
Cash + ST InvestmentsLiquidity on hand
$168.9M
Total DebtLower is stronger
$96.2M
Stockholders' EquityBook value
$196.6M
$127.0M
Total Assets
$899.4M
$264.5M
Debt / EquityLower = less leverage
0.76×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FINW
FINW
OM
OM
Q1 26
Q4 25
$163.4M
$168.9M
Q3 25
$105.6M
$178.6M
Q2 25
$90.1M
$184.1M
Q1 25
$120.3M
$189.0M
Q4 24
$109.2M
$158.7M
Q3 24
$85.8M
$175.6M
Q2 24
$89.0M
$194.8M
Total Debt
FINW
FINW
OM
OM
Q1 26
Q4 25
$96.2M
Q3 25
Q2 25
Q1 25
Q4 24
$197.4M
Q3 24
Q2 24
Stockholders' Equity
FINW
FINW
OM
OM
Q1 26
$196.6M
Q4 25
$193.2M
$127.0M
Q3 25
$187.8M
$142.4M
Q2 25
$182.0M
$154.8M
Q1 25
$177.4M
$169.9M
Q4 24
$173.7M
$26.8M
Q3 24
$170.4M
$47.8M
Q2 24
$165.8M
$68.6M
Total Assets
FINW
FINW
OM
OM
Q1 26
$899.4M
Q4 25
$977.1M
$264.5M
Q3 25
$899.9M
$277.3M
Q2 25
$842.5M
$288.8M
Q1 25
$804.1M
$301.2M
Q4 24
$746.0M
$275.8M
Q3 24
$683.0M
$292.9M
Q2 24
$617.8M
$314.5M
Debt / Equity
FINW
FINW
OM
OM
Q1 26
Q4 25
0.76×
Q3 25
Q2 25
Q1 25
Q4 24
7.36×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FINW
FINW
OM
OM
Operating Cash FlowLast quarter
$-9.5M
Free Cash FlowOCF − Capex
$-9.7M
FCF MarginFCF / Revenue
-33.7%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-47.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FINW
FINW
OM
OM
Q1 26
Q4 25
$-28.4M
$-9.5M
Q3 25
$3.5M
$-6.3M
Q2 25
$-18.3M
$-4.8M
Q1 25
$-21.6M
$-25.7M
Q4 24
$-15.0M
$-16.5M
Q3 24
$-9.8M
$-20.6M
Q2 24
$-7.6M
$-33.3M
Free Cash Flow
FINW
FINW
OM
OM
Q1 26
Q4 25
$-28.6M
$-9.7M
Q3 25
$3.4M
$-6.5M
Q2 25
$-19.8M
$-5.1M
Q1 25
$-23.3M
$-25.8M
Q4 24
$-16.1M
$-16.5M
Q3 24
$-13.4M
$-21.0M
Q2 24
$-7.7M
$-33.5M
FCF Margin
FINW
FINW
OM
OM
Q1 26
Q4 25
-61.1%
-33.7%
Q3 25
9.4%
-22.0%
Q2 25
-79.0%
-16.3%
Q1 25
-105.3%
-86.7%
Q4 24
-76.0%
-56.1%
Q3 24
-64.3%
-73.1%
Q2 24
-38.7%
-122.2%
Capex Intensity
FINW
FINW
OM
OM
Q1 26
Q4 25
0.5%
0.8%
Q3 25
0.1%
0.5%
Q2 25
5.8%
0.9%
Q1 25
7.4%
0.4%
Q4 24
5.1%
0.1%
Q3 24
17.2%
1.4%
Q2 24
0.3%
0.4%
Cash Conversion
FINW
FINW
OM
OM
Q1 26
Q4 25
-7.26×
Q3 25
0.71×
Q2 25
-4.48×
Q1 25
-6.78×
Q4 24
-5.37×
Q3 24
-2.84×
Q2 24
-2.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FINW
FINW

Net Interest Income$28.1M66%
Noninterest Income$14.6M34%

OM
OM

Consumables Product$13.5M47%
Service And Other Revenue$9.0M31%
Consoles Product$6.4M22%

Related Comparisons